Teleflex Incorporated
https://teleflex.com/usa/en/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Teleflex Incorporated
Dealmaking Quarterly Statistics, Q3 2022
During Q3, biopharma merger and acquisition value reached $15.4bn and drew in $37.6bn in potential deal value from alliances. Device company M&A values reached $550m, while in vitro diagnostic firms and research tools players completed M&A activity that totaled $1.9bn.
FDA Announces Class I Recall On Arrow International Cardiac Catheter Device
The US FDA has announced a high-risk class I recall on a cardiac catheter from Teleflex Inc. subsidiary Arrow International due to the risk of tip damage during use.
Glaukos Takes Another Hit From CMS; Investors Respond Negatively As Stock Falls
The US Medicare agency's new rule for facility fees brings more bad news for Glaukos; Wells Fargo downgrades company’s stock in response.
Latest Physician Fee Schedule Proposal Could Impact Companies’ Bottom Line
The US Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that includes new reimbursement levels for multiple medical devices, including the Glaukos iStent.
Company Information
- Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
- Infusion Therapy Equipment and Supplies
- Surgical Equipment & Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
- Other Names / Subsidiaries
-
- Arrow International
- Eon Surgical Ltd
- Hotspur Technologies
- Essential Medical, Inc.
- Hudson Respiratory Care, Inc.
- LMA International N.V.
- NeoTract, Inc.
- Nostix, LLC
- Pyng Medical Corporation
- Semprus BioSciences
- Ultimate Medical
- Vascular Solutions
- Vasonova Inc.
- Vidacare Corporation